| Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer. | breast, |
| Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients. | breast, |
| Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer. | breast, |
| Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer. | lung, |
| c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer. | prostate, |
| Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer. | colorectal, |
| Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. | ovarian, |
| Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization. | leukemia, |
| c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients overall and disease-free survival. | breast, |
| Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma. | kidney, |
| Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. | kidney, |
| Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index. | breast, |
| The c-erbB-2/neu proto-oncogene in human pituitary tumours. | pituitary, |
| [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker]. | kidney, |
| The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix. | uterine, |
| Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma. | endometrial, |
| Amplification of c-erbB-2 proto-oncogene in cancer foci, adjacent normal, metastatic and normal tissues of human primary gastric adenocarcinomas. | gastric, |
| c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions. | cervical, |
| erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody. | breast, |
| [Immunohistochemical study of oncogene c-erbb-2 expression and extracellular matrix proteins in breast cancer (various mechanisms of invasion)]. | breast, |